EP
GH icon

Eversept Partners’s Guardant Health GH Stock Holding History

Eversept Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-276,036
Closed -$8.43M – 65
2024
Q4 		$8.43M Buy
+276,036
New +$7.77M 0.75% 29
2024
Q3 		– Sell
-99,377
Closed -$2.87M – 71
2024
Q2 		$2.87M Sell
99,377
-350,209
-78% -$8.15M 0.2% 56
2024
Q1 		$9.27M Buy
+449,586
New +$9.64M 0.62% 30
2023
Q2 		– Sell
-483,098
Closed -$11.3M – 75
2023
Q1 		$11.3M Buy
483,098
+336,969
+231% +$9.62M 0.79% 26
2022
Q4 		$3.97M Sell
146,129
-25,352
-15% -$1.16M 0.35% 41
2022
Q3 		$9.23M Sell
171,481
-234,894
-58% -$12.1M 0.8% 29
2022
Q2 		$16.4M Buy
406,375
+193,172
+91% +$9.57M 1.17% 28
2022
Q1 		$14.1M Buy
213,203
+112,869
+112% +$7.72M 1.08% 28
2021
Q4 		$10M Sell
100,334
-27
-0% -$2.79K 0.64% 41
2021
Q3 		$12.5M Buy
100,361
+98,552
+5,448% +$11.7M 0.87% 31
2021
Q2 		$225K Sell
1,809
-38,438
-96% -$5.17M 0.02% 87
2021
Q1 		$6.14M Buy
+40,247
New +$6.08M 0.32% 45
2020
Q1 		– Sell
-64,720
Closed -$5.06M – 68
2019
Q4 		$5.06M Buy
+64,720
New +$4.66M 0.89% 32

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Eversept Partners's GH Position: Q1 2025 in Review

Eversept Partners sold out of Guardant Health (GH) in Q1 2025, closing a stake of 276,036 shares — an estimated $8.43M sold.

Eversept Partners first reported a position in GH in Q4 2019 and held it in 13 quarters. The position peaked at $16.4M in Q2 2022. 342 funds tracked by Wall St. Rank hold GH as of Q1 2025.

  • Eversept Partners reported no remaining Guardant Health position as of Q1 2025 after selling out during the quarter.
  • Eversept Partners sold 276,036 Guardant Health shares in Q1 2025, an estimated $8.43M.
  • Eversept Partners first reported a position in Guardant Health in Q4 2019 and held it in 13 quarters.
  • Eversept Partners's Guardant Health position peaked at $16.4M in Q2 2022.
  • 342 funds tracked by Wall St. Rank held Guardant Health as of Q1 2025.

Based on Eversept Partners's 13F filing for Q1 2025, filed 15 May 2025.